Healthcare staffing company AMN Healthcare Services (NYSE:AMN) will be reporting results tomorrow after market close. Here’s what you need to know.
AMN Healthcare Services beat analysts’ revenue expectations by 2.5% last quarter, reporting revenues of $687.5 million, down 19.4% year on year. It was a strong quarter for the company, with a solid beat of analysts’ sales volume estimates.
Is AMN Healthcare Services a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting AMN Healthcare Services’s revenue to decline 15.1% year on year to $694.4 million, improving from the 27.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.49 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMN Healthcare Services has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 1.5% on average.
Looking at AMN Healthcare Services’s peers in the healthcare providers & services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. The Ensign Group delivered year-on-year revenue growth of 15.5%, meeting analysts’ expectations, and Centene reported revenues up 3.4%, topping estimates by 4.4%. The Ensign Group traded down 8.7% following the results while Centene was also down 6.3%.
Read our full analysis of The Ensign Group’s results here and Centene’s results here.
Investors in the healthcare providers & services segment have had fairly steady hands going into earnings, with share prices down 2% on average over the last month. AMN Healthcare Services is down 13.7% during the same time and is heading into earnings with an average analyst price target of $37 (compared to the current share price of $23.39).
Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。